Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tomoki, Sadamatsu"'
Autor:
Shohei Hamada, Hidenori Ichiyasu, Tokunori Ikeda, Megumi Inaba, Kosuke Kashiwabara, Tomoki Sadamatsu, Nahoko Sato, Kimitaka Akaike, Hiroko Okabayashi, Koichi Saruwatari, Yusuke Tomita, Sho Saeki, Naomi Hirata, Takeshi Yoshinaga, Kazuhiko Fujii
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Acute exacerbation of interstitial lung disease (AE-ILD) is the most serious complication in lung cancer patients with pre-existing ILD receiving chemotherapy. The role of vascular endothelial growth factor (VEGF) in pathogenesis
Externí odkaz:
https://doaj.org/article/eb958ef0472f4804a85dcb353ff6677e
Autor:
Shohei Hamada, Hidenori Ichiyasu, Megumi Inaba, Hiroshi Takahashi, Tomoki Sadamatsu, Kimitaka Akaike, Aiko Masunaga, Yasumasa Tashiro, Naomi Hirata, Takeshi Yoshinaga, Takuro Sakagami
Publikováno v:
ERJ Open Research, Vol 6, Iss 2 (2020)
Background The increasing incidence of life-threatening Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients is a global concern. Yet, no reports have examined the prognostic significance of pre-existing interstitial lung disease (ILD)
Externí odkaz:
https://doaj.org/article/e8dc1fbb6d4347cc83f740eb465b6e50
Autor:
Megumi Inaba, Naomi Hirata, Takuro Sakagami, Takeshi Yoshinaga, Kimitaka Akaike, Shohei Hamada, Hidenori Ichiyasu, Tomoki Sadamatsu, Aiko Masunaga, Yasumasa Tashiro, Hiroshi Takahashi
Publikováno v:
ERJ Open Research, Vol 6, Iss 2 (2020)
BackgroundThe increasing incidence of life-threatening Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients is a global concern. Yet, no reports have examined the prognostic significance of pre-existing interstitial lung disease (ILD) i
Autor:
Shohei, Hamada, Hidenori, Ichiyasu, Megumi, Inaba, Hiroshi, Takahashi, Tomoki, Sadamatsu, Kimitaka, Akaike, Aiko, Masunaga, Yasumasa, Tashiro, Naomi, Hirata, Takeshi, Yoshinaga, Takuro, Sakagami
Publikováno v:
ERJ Open Research
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Background The increasing incidence of life-threatening Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients is a global concern. Yet, no reports have examined the prognostic significance of pre-existing interstitial lung disease (ILD)
Autor:
Sho Saeki, Takeshi Yoshinaga, Yusuke Tomita, Koichi Saruwatari, Kimitaka Akaike, Nahoko Sato, Shohei Hamada, Kazuhiko Fujii, Megumi Inaba, Hiroko Okabayashi, Tomoki Sadamatsu, Tokunori Ikeda, Naomi Hirata, Hidenori Ichiyasu, Kosuke Kashiwabara
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Pulmonary Medicine
BMC Pulmonary Medicine
Background Acute exacerbation of interstitial lung disease (AE-ILD) is the most serious complication in lung cancer patients with pre-existing ILD receiving chemotherapy. The role of vascular endothelial growth factor (VEGF) in pathogenesis of AE-ILD